Comprehensive clinical reference for GCC nurses managing GBS — from respiratory monitoring and IVIg/PE treatment to rehabilitation and GCC exam preparation.
CSF protein — >0.45 g/L (normal cells) = classic GBS
Steroids — NOT effective in GBS (harmful)
Nadir — Typically 2–4 weeks from onset
🧬
What is Guillain-Barré Syndrome?
GBS is an acute immune-mediated polyneuropathy. Following an infection (usually 1–4 weeks prior), the immune system mistakenly attacks the peripheral nervous system — targeting either the myelin sheath or the axons themselves.
ℹ️Core mechanism: Molecular mimicry — antigens on infecting organisms resemble gangliosides on nerve membranes. Antibodies cross-react, causing demyelination or axonal damage and resulting in weakness, areflexia, and sensory changes.
Preceding Infections (Triggers)
Organism
Route / Relevance
GCC Relevance
Campylobacter jejuni
Most common trigger — contaminated poultry/water
High — Hajj outbreaks
Cytomegalovirus (CMV)
Often associated with Miller Fisher variant
Immunocompromised patients
Epstein-Barr virus (EBV)
Mononucleosis preceding GBS
Young adults
Mycoplasma pneumoniae
Atypical pneumonia preceding GBS
Community acquired
Zika virus
Strong epidemiological link to GBS
Travel risk — S. Asia, Africa
COVID-19 / SARS-CoV-2
Recognised trigger, emerging data
Pandemic-era awareness
Influenza vaccine
Very rare association (~1–2 per million doses)
Context for patient questions
GCC Context — Epidemiology
Hajj pilgrimage creates mass-gathering conditions with increased Campylobacter contamination risk from food handling at scale. Healthcare workers in Saudi Arabia, Qatar, and UAE should be aware of GBS clusters post-Hajj season. Zika virus remains a risk for patients travelling from or returning to endemic regions in South/Southeast Asia and Sub-Saharan Africa.
🔬
GBS Variants
Variant
Full Name
Mechanism
Features
Antibody
AIDP
Acute Inflammatory Demyelinating Polyneuropathy
Demyelinating
Most common (85–90% in West). Classic ascending weakness + areflexia
Various
AMAN
Acute Motor Axonal Neuropathy
Axonal (motor only)
Common in Asia. Often post-Campylobacter. Can be more severe. Pure motor.
Anti-GM1, Anti-GD1a
AMSAN
Acute Motor-Sensory Axonal Neuropathy
Axonal (motor + sensory)
Severe. Slower recovery. Both motor and sensory axons affected.
Anti-GM1, Anti-GD1b
MFS
Miller Fisher Syndrome
Ganglioside GQ1b
Triad: ophthalmoplegia + ataxia + areflexia. No or minimal limb weakness.
Anti-GQ1b
📌Exam tip: Miller Fisher Syndrome triad = Ophthalmoplegia + Ataxia + Areflexia. Anti-GQ1b antibody is virtually diagnostic. Bulbar involvement can occur — monitor swallowing.
📋
Classic Presentation & Disease Course
Typical Symptoms at Presentation
Ascending bilateral limb weakness — legs first
Areflexia (loss of deep tendon reflexes)
Back pain and limb pain (often early)
Sensory changes — paraesthesia, numbness
Facial weakness (bilateral facial nerve palsy)
Bulbar symptoms — dysarthria, dysphagia
Autonomic dysfunction — labile BP, HR variability
Disease Trajectory
1
Prodrome
Infection 1–4 weeks prior. Mild fatigue, back pain.
2
Progressive Phase
Ascending weakness progresses. Nadir at 2–4 weeks.
3
Plateau Phase
Weakness at maximum. Respiratory risk highest here.
4
Recovery Phase
Weeks to months. Often incomplete. Fatigue persists.
Functional Severity Scale
Grade
Description
Setting
0
Healthy, normal
Community
1
Minor symptoms — able to run
Community
2
Able to walk 10m independently
Ward
3
Walks 10m with support / walker
Ward / HDU
4
Bedbound or chair-bound
HDU
5
Requiring assisted ventilation
ICU
6
Death
ICU
🚨Critical: Respiratory failure is the leading cause of death in GBS. Up to 30% of patients require mechanical ventilation. Anticipate and act early — do not wait for oxygen saturation to fall. Plan elective intubation.
⚠️
The 20/30/40 Rule — Respiratory Monitoring
The 20/30/40 rule defines thresholds for respiratory compromise. Any single criterion meeting the threshold mandates immediate senior review and consideration of elective intubation.
20
ml/kg FVC
Vital capacity <20 ml/kg — intubation threshold
30
kPa PaO2
PaO2 <30 kPa on room air — respiratory failure
40
PaO2/FiO2
P/F ratio <40 — impending critical failure
⚠️Key principle: Do not wait for SpO2 to drop or for the patient to look distressed. Patients with GBS can maintain oxygen saturation until late-stage exhaustion. The trend in FVC is more important than any single value.
📊
Serial Respiratory Function Monitoring
FVC Monitoring Protocol
Measure FVC every 4–6 hours in progressive GBS (or more frequently if declining)
Urinary catheter — monitor output, bladder scan if needed
Ileus / constipation
Reduced gut motility from autonomic involvement
Aperients, bowel chart, NG feeds if ileus
Sweating abnormalities
Anhidrosis or hyperhidrosis
Temperature monitoring, skin care
🚨Autonomic crisis: Sudden bradycardia during suction or position change is a recognised emergency in GBS. Have atropine available at bedside. Avoid activities that trigger vagal responses without preparation.
🏥
ICU / HDU Admission Criteria
Indications for ICU/HDU
FVC declining — especially if <20 ml/kg
Bulbar palsy (unsafe swallow, weak cough)
Dysautonomia (labile BP, arrhythmia)
Rapid progression — weakness progressing daily
Inability to stand/walk (grade 4–5)
Significant hypoxia (SpO2 <95% on air)
Respiratory Bundle (Ward Level)
Nurse at 30° upright — reduces aspiration risk
Cough assist device — if available and cough weak
Suction equipment at bedside and checked
Nasopharyngeal airway available (bulbar risk)
Emergency call equipment immediately accessible
FVC trending documented each shift
ℹ️Elective vs emergency intubation: Plan elective intubation when FVC is 15–20 ml/kg, before the patient deteriorates. Emergency intubation in a paralysed, panicked patient is hazardous. Early discussion with ICU/anaesthetics is essential when FVC is declining.
🔴
GBS Respiratory Deterioration Monitor
Enter clinical parameters to generate a risk category and nursing actions. This tool is for educational guidance only — always escalate to senior clinicians.
Step 1 — Enter Patient Parameters
Raw FVC (litres)
Patient weight (kg)
FVC trend
Swallowing assessment
Bulbar symptoms
Autonomic instability
Step 2 — Serial FVC Trend Tracker
Enter up to 3 consecutive FVC readings (in ml/kg) with times to display the trend direction.
🔬
Diagnostic Investigations
Lumbar Puncture — CSF Analysis
CSF Parameter
GBS Finding
Normal
Significance
Protein
>0.45 g/L (often 1–10 g/L)
0.15–0.45 g/L
Elevated due to blood-nerve barrier disruption
WBC (cells)
<10 cells/mm³
<5 cells/mm³
Normal or near-normal — key differentiating feature
Pattern
Cytoalbuminous dissociation
High protein + normal cells = classic GBS. Can be normal in first 48h.
Glucose
Normal
Normal
Unlike meningitis — glucose normal in GBS
⚠️Important: LP may be normal in the first 24–48 hours. A normal LP does not exclude GBS. Clinical diagnosis is primary — do not delay treatment awaiting LP results.
✅Evidence base: IVIg and plasma exchange are equally effective in GBS. Do not combine them — no additional benefit and increased complications. Choose one based on availability, access, and patient factors.
Nursing: IV calcium gluconate at bedside during sessions. Check ionised calcium pre/post each session.
🚫Steroids are NOT recommended in GBS. Randomised trials show corticosteroids provide no benefit and may cause harm (slower recovery in some studies). Do not administer steroids for GBS alone.
Pain Management in GBS
Neuropathic pain affects up to 89% of GBS patients and can be severe. It is often underrecognised.
Pain Type
Treatment
Notes
Neuropathic (burning, shooting)
Gabapentin, Pregabalin, Carbamazepine
First-line for neuropathic component
Musculoskeletal / back pain
Paracetamol, NSAIDs (if no contraindication)
Positioning and physio also essential
Severe / refractory pain
Opioids (tramadol, morphine)
Monitor for respiratory depression — use cautiously
🛡️
Immobility Complications Prevention
DVT Prophylaxis
LMWH (e.g. enoxaparin) — unless contraindicated
TED compression stockings — correctly measured and applied
Pneumatic compression devices if prescribed
Early passive mobilisation when clinically safe
Adequate hydration
Pressure Area Care
2-hourly repositioning — document on repositioning chart
Pressure-relieving mattress (minimum dynamic air)
Heel protection — foam boots or pillows under calves
Padded splints for foot drop prevention
Skin assessment each shift — document Waterlow score
Strict fluid balance — input and output charted hourly
Clean technique and daily catheter care
Monitor for UTI — common in catheterised patients
Eye Care (Facial Nerve Involvement)
Assess for incomplete eye closure (lagophthalmos)
Artificial tears — 4-hourly minimum if eyes not fully closing
Moisture eye shields or tape at night
Regular ophthalmology review if prolonged exposure
🍽️
Nutrition & Bowel Management
Nutritional Support
Daily swallowing assessment by SLT or trained nurse
If unsafe swallow — insert NG tube and initiate tube feeding
Nil by mouth until swallowing formally assessed
Commence NG feeds with dietitian input
Monitor for aspiration (temperature, secretions)
Head of bed 30–45° during and after feeding
Bowel Management
Constipation common — autonomic gut dysmotility
Bowel chart — document frequency and consistency
Aperients (lactulose, senna) — initiate early
Adequate hydration and fibre in feeds
Monitor for ileus — if absent bowel sounds or distension, NG tube and IV fluids
😰
Pain Assessment & Psychological Support
Pain Assessment
Use NRS (Numerical Rating Scale 0–10) — document location and character
Neuropathic pain often burning, shooting, allodynia
If intubated/unable to communicate — use CPOT or BPS scale
Administer regular analgesia — do not PRN-only for constant pain
Reassess within 1 hour of any analgesic given
Psychological Support
💬GBS is a terrifying condition. Patients may be fully conscious and aware while completely paralysed and unable to communicate. High rates of anxiety, depression, and post-traumatic stress.
Establish communication system early (alphabet boards, eye-blink coding, AAC devices)
Regular reassurance — explain every procedure and touch first
Involve family in care and communication
Early psychology or psychiatric referral
Sleep hygiene — noise reduction, lighting control
📝
GBS Nursing Care Bundle — Checklist
Every Shift
FVC (weight-corrected) + trend documented
Swallowing status reassessed
Neuro obs — power in each limb
Pain assessment (NRS)
Bowel and fluid balance chart
Skin assessment + repositioning
Eye care if facial nerve involved
Communication needs met
Daily
SLT swallowing review
Physiotherapy passive ROM
Catheter care + CAUTI check
DVT stockings + LMWH given
Weight (adjust FVC threshold)
Psychological welfare check
Waterlow risk score update
Escalate If
FVC <20 ml/kg or declining fast
Unsafe swallow — unsafe to eat
SpO2 <95% on air
Labile BP or new arrhythmia
New weakness (rapid progression)
Signs of aspiration
Patient distress / panic episode
📈
Recovery Trajectory
Most GBS patients recover, but recovery is often slow and incomplete. Patient and family education about realistic timelines is essential.
Timeframe
Expected Progress
Nursing Focus
0–4 weeks
Progression to nadir — respiratory risk highest
Respiratory monitoring, prevention of complications
4–8 weeks
Plateau / early recovery begins
Maintain nutrition, prevent deconditioning
3–6 months
Active motor recovery — most functional gains
Active physiotherapy, OT, rehab goals
6–12 months
Ongoing recovery — 20% still need walking aid at 6 months
Community rehab, fatigue management
>12 months
Further slow recovery possible; some residual deficit
Long-term pain clinic, psychosocial support
⚠️Autonomic recovery typically precedes motor recovery. Return of reflexes often precedes strength. Recovery follows a proximal-to-distal pattern in most patients.
🏃
Multidisciplinary Rehabilitation Team
Physiotherapy
Acute phase: passive ROM exercises — prevent contractures
Positioning: anti-spasticity positions, splints for foot drop
Patient Education — Prevention of Recurrence / Campylobacter
GBS recurs in ~2–5% of patients. Advise patients on Campylobacter food hygiene: thorough cooking of poultry, avoiding cross-contamination, hand hygiene after raw meat handling. In GCC settings, discuss safe food practices at gatherings (Hajj, weddings, communal meals). Zika-related GBS: advise on mosquito bite prevention when travelling to endemic areas.
📚The following topics are high-yield for GCC nursing licensing examinations (DHA, DOH, SCFHS, QCHP, HAAD, NHRA). Review each section carefully before your exam.
The 20/30/40 Rule (Critical Exam Point)
Number
Parameter
Threshold
Action
20
Vital capacity (FVC)
<20 ml/kg
Consider intubation — discuss with ICU/anaesthetics
30
PaO2 on room air
<30 kPa
Supplemental O2 + urgent senior review
40
PaO2/FiO2 ratio
<40
Impending respiratory failure — immediate ICU
IVIg vs Plasma Exchange — Exam Comparison
Feature
IVIg
Plasma Exchange
Efficacy
Equal — either is first-line
Access required
Peripheral IV (large bore)
Central venous access (double-lumen)
Dose
2 g/kg over 5 days
5 sessions over 2 weeks
Key side effects
Anaphylaxis (check IgA), headache, thrombosis
Hypocalcaemia, hypotension, clotting line
Monitoring
IgA levels pre-treatment
Ionised calcium each session
Can be combined?
NO — combination shows no additional benefit
Classic CSF Findings
📌Cytoalbuminous dissociation: High protein (>0.45 g/L) with normal or near-normal cell count (<10 WBC/mm³). This is a classic exam answer. Note: may be normal in the first 48 hours of illness.
GBS vs Miller Fisher Syndrome
Feature
Classic GBS (AIDP)
Miller Fisher Syndrome (MFS)
Weakness
Ascending limb weakness — legs first
Minimal or absent limb weakness
Reflexes
Areflexia (universal)
Areflexia (part of triad)
Eye movements
Usually preserved
Ophthalmoplegia — diplopia, ptosis
Gait
Weak, may be non-ambulant
Ataxia — cerebellar-type
Antibody
Various (anti-GM1, etc.)
Anti-GQ1b (85–90% positive)
Respiratory risk
High — up to 30% need ventilation
Lower — but bulbar involvement can occur
❓
GBS Quick Quiz — GCC Exam Preparation
1. A GBS patient has FVC of 1.2L and weighs 70kg. What is the FVC in ml/kg and what action is required?
2. What is the classic CSF finding in GBS that distinguishes it from bacterial meningitis?
3. Which treatment has been shown to be harmful in GBS and should NOT be administered?
4. A patient with GBS develops perioral tingling and muscle cramps during plasma exchange. What is the most likely cause?
5. Miller Fisher Syndrome presents with which classic triad?
6. Which organism is most commonly associated with preceding Guillain-Barré Syndrome and is particularly relevant in the context of Hajj pilgrimage?
7. An intubated GBS patient who is fully conscious cannot communicate. Which intervention should the nurse prioritise?
8. Which antibody is most closely associated with Miller Fisher Syndrome?